High-quality, clinically proven prostate support
- Promotes prostate health
- Superior urinary tract support
- A carefully crafted blend of European pollen extracts
$54.96 — or subscribe and get 20% off
When it comes to men, making sure to maintain prostate health is as important as taking care of their overall health. In the United States, many men face some sort of prostate issue at some point in their lives, usually presenting in late middle age. Therefore, it is important for men of all ages to take steps in their daily lives to support, protect, and maintain prostate health.
AOR’s Prostaphil-2™ provides an exciting solution for prostate health by utilizing botanical defined-pollen extract to target several prostate issues, support liver function, and provide antioxidant protection. Although the mechanism of action of defined-pollen extract remains unclear, studies suggest that it may reduce the inflammatory response while balancing the muscles of the urethra and bladder, which can help explain the effects of the extract on various prostate symptoms.
AOR’s Prostaphil-2™ is a premium supplement that helps reduce prostate volume and the inflammatory response.
Prostaphil-2™ is defined-pollen extract first crafted in Sweden. This non-bee pollen is produced by blending fat- and water-soluble extracts from specific pollens to provide superior support for prostate health.*
AOR™ guarantees that all ingredients have been declared on the label. Made without wheat, gluten, nuts, peanuts, sesame seeds, sulfites, mustard, soy, dairy, eggs, fish, shellfish.
Take 1 capsule 1-3 times daily with or without food, or as directed by a qualified health care practitioner.
Consult your physician before use if you are pregnant, lactating, have a medical condition, or are taking any medication. Keep out of reach of children.
Consult a health care practitioner prior to use to exclude a diagnosis of prostate cancer. Hypersensitivity has been known to occur, in which case discontinue use. May cause mild gastrointestinal discomfort or nausea. Do not use if you are allergic to flower pollen.
Rye (Secale cereale), Corn (Zea mays) & Timothy-grass (Phleum pretense)
- Prostate health
- Urinary tract support
*These statements have not been approved by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
† Daily value not established
Other Ingredients: calcium hydrogen phosphate dihydrate, calcium gluconate, microcrystalline cellulose, Capsule (hypromellose, glycerin and purified water), silicon dioxide, maltodextrin (corn), and sodium stearyl fumarate.
Andriole GL, McCullum-Hill C, Sandhu GS, Crawford ED, Barry MJ, Cantor A; CAMUS Study Group. The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial. J Urol. 2013 Feb;189(2):486-92.
Becker H, Ebeling L. Phytotherapy of BPH with cernilton N – results of a controlled prospective study. Urologe (B) 1991; 31: 113-6.
Blumenthal M (ed). The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines. Austin, TX: American Botanical Council, 1998.
Brauer H. The treatment of benign prostatic hyperplasia with phytopharmata: a comparative study of cernilton vs. beta-sitosterol. Therapiewoche. 1986; 36: 1686-96.
Buck AC, Cox R, Rees RW, Ebeling L, John A. Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study. Br J Urol. 1990 Oct; 66(4): 398-404.
Dutkiewicz S. Usefulness of Cernilton in the treatment of benign prostatic hyperplasia. Int Urol Nephrol. 1996; 28(1): 49-53.
Ebeling L. Therapeutic results of defined pollen-extract in patients with chronic prostatis or BPH accompanied by chronic prostatitis. In , Schmiedt E, Alken JE, Bauer HW (eds). Therapy of Prostatitis. Munich: Zuckerschwerdt Verlag, 1986; 154-60.
Jaton JC, Roulin K, Rose K, Sirotnak FM, Lewenstein A, Brunner G, Fankhauser CP, Burger U. The secalosides, novel tumor cell growth inhibitory glycosides from a pollen extract. J Nat Prod. 1997 Apr; 60(4): 356-60.
Maekawa M, Kishimoto T, Yasumoto R, Wada S, Harada T, Ohara T, Okajima E, Hirao Y, Ohzono S, Shimada K, et al. Clinical evaluation of cernilton on benign prostatic hypertrophy – a multiple center double-blind study with Paraprost. Hinyokika Kiyo. 1990 Apr; 36(4): 495-516.
Roberts KP, Iyer RA, Prasad G, Liu LT, Lind RE, Hanna PE. Cyclic hydroxamic acid inhibitors of prostate cancer cell growth: selectivity and structure activity relationships. Prostate. 1998 Feb 1; 34(2): 92-9.
Yasumoto R, Kawanishi H, Tsujino T, Tsujita M, Nishisaka N, Horii A, Kishimoto T. Clinical evaluation of long-term treatment using cernitin pollen extract in patients with benign prostatic hyperplasia. Clin Ther. 1995 Jan-Feb; 17(1): 82-7.
Zhang X, Habib FK, Ross M, Burger U, Lewenstein A, Rose K, Jaton JC. Isolation and characterization of a cyclic hydroxamic acid from a pollen extract, which inhibits cancerous cell growth in vitro. J Med Chem. 1995 Feb 17; 38(4): 735-8.